Table 2.

Baseline patient characteristics by panel proximity quintile*

CHARACTERISTICPATIENT PANEL PROXIMITY QUINTILE
1(n=546,555)2(n=541,332)3(n=540,733)4(n=531,296)5(n=530,566)OVERALL(N=2,690,482)
Patient proximity, km, mean (SD)3.9 (0.6)5.3 (0.3)6.4 (0.3)7.8 (0.6)12.5 (3.7)7.1 (3.4)
    • Median (IQR)4.0 (3.4-4.4)5.3 (5.1-5.5)6.4 (6.0-6.6)7.7 (7.3-8.3)11.4 (9.9-13.5)6.3 (5.1-8.2)
Age, y, mean (SD)47.6 (16.4)47.2 (16.4)46.9 (16.3)46.9 (16.5)47.2 (16.8)47.2 (16.5)
Male, %45.347.048.749.648.847.9
Study follow-up time, y, mean (SD)4.9 (0.5)4.9 (0.5)4.9 (0.5)4.9 (0.6)4.9 (0.6)4.9 (0.6)
Immigrant, %35.219.716.711.15.017.6
    • <10 y in Ontario, %14.48.87.95.52.57.8
    • 10-20 y in Ontario, %18.39.37.54.82.18.5
Ethnicity (among immigrants), %
    • Black8.313.712.811.511.310.9
    • East Asian26.610.212.48.07.116.8
    • Latin American7.07.86.67.57.47.2
    • South Asian29.026.528.126.123.827.6
    • Southeast Asian9.29.77.57.55.88.6
    • West Asian5.410.411.412.18.68.7
    • White Eastern European10.114.512.915.515.212.6
    • White Western European3.66.17.210.519.56.6
    • Unknown0.91.11.11.31.31.0
Neighbourhood income quintile, %
    • 1 (lowest)21.918.317.717.617.118.5
    • 223.519.919.118.818.820.0
    • 320.720.320.119.920.820.4
    • 418.620.721.421.622.220.9
    • 515.320.721.722.121.120.2
    • Unknown0.10.20.20.40.30.2
Current smoker or quit in past year, survey weight adjusted, %17.319.623.024.525.722.0
Hypertension, %26.625.024.224.525.325.1
Diabetes, %11.89.99.18.88.59.6
Total cholesterol, mmol/L, mean (SD)§5.05 (1.01)5.10 (1.02)5.11 (1.04)5.10 (1.04)5.15 (1.06)5.10 (1.03)
HDL, mmol/L, mean (SD)§1.45 (0.40)1.46 (0.41)1.45 (0.41)1.44 (0.41)1.45 (0.41)1.45 (0.41)
  • HDL—high-density lipoprotein, IQR—interquartile range.

  • * P value <.05 for differences between proximity quintiles on all characteristics.

  • Closest-proximity quintile.

  • From a subpopulation of 32,518 respondents to the 2005 to 2012 cycles of the Canadian Community Health Survey.25

  • § From a subpopulation of 673,586 patients with testing performed at Dynacare Medical Laboratories.